Camber Capital Management LP Gilead Sciences, Inc. Call Options Transaction History

Camber Capital Management LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $33.8 Million - $36.5 Million	500,000 Added 50.0%	1,500,000 $105 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $95.2 Million - $104 Million	-1,500,000 Reduced 60.0%	1,000,000 $68.9 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $142 Million - $161 Million	2,500,000 New	2,500,000 $146 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.